
Hanne Leth Hillman joins Zealand Pharma
pharmafile | January 13, 2011 | Appointment | Medical Communications | Hanne Leth Hillman, Zealand Pharma, appointment, medical communications
Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications.
She will join Zealand Pharma from NeuroSearch, where she was director of investor relations (IR) and capital market relations, and has more than 15 years of experience in equity markets and the life science industry.
“Hanne’s deep understanding of the investor community and comprehensive biotech expertise brings all the competencies we need to communicate clearly and effectively with our shareholders, potential investors and other key external stakeholders,” said David Solomon, president and chief executive of Zealand Pharma.
“Following the recent IPO of Zealand Pharma, we look forward to building our IR programme, and Hanne will play a leading role in the further development of our investor and media relations.”
Hanne will begin her work in Zealand Pharma on 1 March 2011 and will report to David Solomon.
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






